<DOC>
	<DOCNO>NCT00974181</DOCNO>
	<brief_summary>Two consecutive cohort subject treat CoStar stent load different paclitaxel dose regimen . The first 145 subject ( Arm I ) , enrol 20 January 2004 26 May 2004 , treat 10 µg paclitaxel subsequent 137 subject ( Arm II ) , enrol 15 December 2004 9 March 2005 , treat 30 µg paclitaxel . Both dose formulation elute 30 day ( in-vitro ) . Subjects arm complete clinical follow-up 1 , 6 12 month post-index procedure , angiographic follow-up 6 month outline original study protocol . Based result previous study initial EuroSTAR Trial result , Conor Medsystems decide pursue dosage use Arm I , 10 μg/30 day , commercial dose formulation CoStar® stent . The EuroSTAR Trial addendum propose purpose evaluate long-term clinical outcome CoStar stent .</brief_summary>
	<brief_title>The European Cobalt STent With Antiproliferative Restenosis Trial ( EuroSTAR Trial )</brief_title>
	<detailed_description>The EuroSTAR Trial ( European Cobalt STent Antiproliferative Restenosis Trial ) prospective , multi-center , two-arm study evaluate safety performance CoStar® stent treatment symptomatic ischemic heart disease attributable stenotic de novo lesion native coronary artery amenable treatment percutaneous stenting .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<criteria>All subject admit PCI screen study eligibility . The subject must meet follow criterion inclusion Study : 1 . Subject ≥ 1880 year age , 2 . Subject understands risk , benefit alternative Percutaneous Coronary Intervention ( PCI ) sign Informed Consent approve Institution implantation COSTAR™ stent , 3 . Subject willing able return clinical angiographic follow , 4 . Subject acceptable candidate plan PCI , 5 . Subject stable unstable angina pectoris ( CCS Classification I great ) , positive functional study ischemia , 6 . Subject male , female subject postmenopausal nonchild bearing potential , and/or negative pregnancy test time PCI , 7 . No treatment plan within 30 day procedure . Up two lesion may treat use COSTAR™ stent per study subject , either two discreet lesion one vessel separate &gt; 20mm two discreet lesion two native coronary artery . Upon coronary angiography time PCI , lesion consideration treatment must meet follow angiographic criterion inclusion study : 8 . The target lesion denovo lesion native coronary artery treat previous interventional procedure , 9 . The target lesion meet follow angiographic criterion visual assessment Investigator : 1 . The target lesion stenosis must 5099 % , 2 . The target reference vessel diameter 2.5 mm 3.5mm , 3 . The lesion length ≤25 mm , 4 . Target vessel Thrombolysis Myocardial Infarction ( TIMI ) flow must grade 1 high . 1 . Subject leave ventricular ejection fraction &lt; 30 % , 2 . Subject imminent comorbid illness ( i.e. , life expectancy le 2 year ) , 3 . Subject experience acute myocardial infarction ( MI ) 72 hour prior procedure , define either presence new Q wave 2 contiguous lead , CK great two time site upper limit normal value presence CKMB great site upper limit normal value , 4 . Subject know allergy hypersensitivity cobalt steel , contrast medium , heparin , aspirin , 5 . Subject history allergic reaction hypersensitivity paclitaxel drug similar class , 6 . Subject contraindicate unwilling take aspirin clopidogrel ticlopidine , 7 . Subject know peptic ulcer recent ( &lt; 3 month GI bleeding , 8 . Subject cerebrovascular event ( CVA ) transient ischemic attack ( TIA ) within prior 6 month , 9 . Subject renal failure define serum creatinine level &gt; 2.5 mg/dL , 10 . Subject cardiogenic shock , 11 . Subject unstable ventricular arrhythmia , 12 . Subject currently enrol another investigational drug device trial , 13 . Subject undergone PCI CABG surgery within 30 day procedure , 14 . Subject unable comply follow requirement , would unreliable follow documentation . Upon coronary angiography time PCI , lesion exclude study follow angiographic criterion meet : 15 . More 2 lesion require treatment time procedure 16 . Presence intraluminal thrombus target vessel 17 . The target lesion involve bifurcation adjacent vessel great 2 mm diameter require intervention 18 . Patient evolve myocardial infarction evidence persistent new ECG change PCI ( define new ST segment elevation depression &gt; 1.0 mm &gt; 30 min ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>